Overview

Pharmacokinetics and Safety Study of PT010 and PT003 in Healthy Chinese Adult Subjects

Status:
Completed
Trial end date:
2017-09-05
Target enrollment:
Participant gender:
Summary
A study to assess the pharmacokinetics and safety of two doses of PT010 and a single dose of PT003 in healthy Chinese adult subjects
Phase:
Phase 1
Details
Lead Sponsor:
Pearl Therapeutics, Inc.
Treatments:
Budesonide
Formoterol Fumarate
Glycopyrrolate